These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31729256)

  • 1. Effectiveness, Safety, and Economic Comparison of Inhaled Epoprostenol Brands, Flolan and Veletri, in Acute Respiratory Distress Syndrome.
    Hawn JM; Bauer SR; Wanek MR; Li M; Wang X; Duggal A; Torbic H
    Ann Pharmacother; 2020 May; 54(5):434-441. PubMed ID: 31729256
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness, safety, and Economic Comparison of Two Inhaled Epoprostentol Products (Flolan and Veletri) in Cardiothoracic Surgery Patients.
    Hawn JM; Wanek M; Bauer SR; Ammar MA; Insler S; Adi A; Torbic H
    Ann Pharmacother; 2018 Oct; 52(10):956-964. PubMed ID: 29749260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Economic Impact of Formulary Conversion From Inhaled Flolan to Inhaled Veletri for Refractory Hypoxemia in Critically Ill Patients.
    Torbic H; Szumita PM; Anger KE; Nuccio P; Lagambina S; Weinhouse G
    Ann Pharmacother; 2016 Feb; 50(2):106-12. PubMed ID: 26668204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninferiority of Inhaled Epoprostenol to Inhaled Nitric Oxide for the Treatment of ARDS.
    Ammar MA; Bauer SR; Bass SN; Sasidhar M; Mullin R; Lam SW
    Ann Pharmacother; 2015 Oct; 49(10):1105-12. PubMed ID: 26187741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of inhaled prostacyclin in treating acute respiratory distress syndrome.
    Searcy RJ; Morales JR; Ferreira JA; Johnson DW
    Ther Adv Respir Dis; 2015 Dec; 9(6):302-12. PubMed ID: 26294418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective evaluation of inhaled prostaglandins in patients with acute respiratory distress syndrome.
    Camamo JM; McCoy RH; Erstad BL
    Pharmacotherapy; 2005 Feb; 25(2):184-90. PubMed ID: 15767234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled epoprostenol to support the severely hypoxemic patient with acute respiratory distress syndrome.
    Arumpanayil A
    Dimens Crit Care Nurs; 2013; 32(5):229-36. PubMed ID: 23933641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled prostaglandin E1 for treatment of acute lung injury in severe multiple organ failure.
    Meyer J; Theilmeier G; Van Aken H; Bone HG; Busse H; Waurick R; Hinder F; Booke M
    Anesth Analg; 1998 Apr; 86(4):753-8. PubMed ID: 9539597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responsiveness of Inhaled Epoprostenol in Respiratory Failure due to COVID-19.
    Sonti R; Pike CW; Cobb N
    J Intensive Care Med; 2021 Mar; 36(3):327-333. PubMed ID: 33234007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled epoprostenol vs inhaled nitric oxide for refractory hypoxemia in critically ill patients.
    Torbic H; Szumita PM; Anger KE; Nuccio P; LaGambina S; Weinhouse G
    J Crit Care; 2013 Oct; 28(5):844-8. PubMed ID: 23683572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severity of Hypoxemia and Other Factors That Influence the Response to Aerosolized Prostacyclin in ARDS.
    Kallet RH; Burns G; Zhuo H; Ho K; Phillips JS; Pangilinan LP; Yip V; Gomez A; Lipnick MS
    Respir Care; 2017 Aug; 62(8):1014-1022. PubMed ID: 28559468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nebulized prostacyclin (PGI2) in acute respiratory distress syndrome: impact of primary (pulmonary injury) and secondary (extrapulmonary injury) disease on gas exchange response.
    Domenighetti G; Stricker H; Waldispuehl B
    Crit Care Med; 2001 Jan; 29(1):57-62. PubMed ID: 11176161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of Converting Inhaled Epoprostenol Product From Flolan to Veletri in Critically Ill Patients.
    Torbic H; Bauer SR; Wanek MR
    Am J Ther; 2020 Oct; 28(6):e781-e785. PubMed ID: 33021539
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhaled epoprostenol improves oxygenation in severe hypoxemia.
    Tabrizi MB; Schinco MA; Tepas JJ; Hwang J; Spiwak E; Kerwin AJ
    J Trauma Acute Care Surg; 2012 Aug; 73(2):503-6. PubMed ID: 23019678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled nitric oxide and inhaled prostacyclin in acute respiratory distress syndrome: what is the evidence?
    Puri N; Dellinger RP
    Crit Care Clin; 2011 Jul; 27(3):561-87. PubMed ID: 21742217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Fixed-Dose Inhaled Epoprostenol and Inhaled Nitric Oxide for Acute Respiratory Distress Syndrome in Critically Ill Adults.
    Buckley MS; Agarwal SK; Garcia-Orr R; Saggar R; MacLaren R
    J Intensive Care Med; 2021 Apr; 36(4):466-476. PubMed ID: 32133901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group.
    Abraham E; Baughman R; Fletcher E; Heard S; Lamberti J; Levy H; Nelson L; Rumbak M; Steingrub J; Taylor J; Park YC; Hynds JM; Freitag J
    Crit Care Med; 1999 Aug; 27(8):1478-85. PubMed ID: 10470753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epoprostenol (Veletri®, Caripul®): a review of its use in patients with pulmonary arterial hypertension.
    Greig SL; Scott LJ; Plosker GL
    Am J Cardiovasc Drugs; 2014 Dec; 14(6):463-70. PubMed ID: 25312243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use and costs of inhaled nitric oxide and inhaled epoprostenol in adult critically ill patients: A quality improvement project.
    Davis SL; Crow JR; Fan JR; Mattare K; Whitman G; Brower RG; Rowden A; Pustavoitau A
    Am J Health Syst Pharm; 2019 Sep; 76(18):1413-1419. PubMed ID: 31372630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled prostacyclin (PGI2) versus inhaled nitric oxide in adult respiratory distress syndrome.
    Zwissler B; Kemming G; Habler O; Kleen M; Merkel M; Haller M; Briegel J; Welte M; Peter K
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1671-7. PubMed ID: 8970353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.